Recursion Pharmaceuticals Selects Anaconda to Create Innovative Next Generation Drug …

Continuum Analytics, the creator and driving force behind Anaconda, a leading open data science platform powered by Python, announced that Recursion Pharmaceuticals, LLC, a drug discovery company focused on rare genetic diseases, is using Bokeh––a Continuum Analytics open source visualization framework that operates on the Anaconda platform. Bokeh on Anaconda makes it easy for biologists to identify genetic disease markers and assess drug efficacy when visualizing cell data, allowing for faster time-to-value for pharmaceutical companies. Continuum Analytics’ Bokeh on Anaconda enables us to perform analyses and make informative, actionable decisions that are driving real change in the treatment of rare genetic diseases,” said Blake Borgeson, CTO & co-founder at Recursion Pharmaceuticals. “ By layering information and viewing images interactively, we are obtaining insights that were not previously possible and enabling our biologists…


Link to Full Article: Recursion Pharmaceuticals Selects Anaconda to Create Innovative Next Generation Drug …